Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs
Go back to Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs| StemCells, Inc. (NASDAQ: TEM) | Delayed: 64.62 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.62 | 52 Week High | $0.45 | |||
| Open | $64.62 | 52 Week Low | $0.37 | |||
| Day High | $64.62 | P/E | N/A | |||
| Day Low | $64.62 | EPS | $-0.31 | |||
| Volume | 89,942 | |||||

